-100
NPS Score
VS
Acorda Therapeutics
- EMPLOYEE
PARTICIPANTS - 5
- TOTAL
RATINGS
Avanir Pharmaceuticals
- EMPLOYEE
PARTICIPANTS - 3
- TOTAL
RATINGS
Acorda Therapeutics vs Avanir Pharmaceuticals
Compare Acorda Therapeutics versus Avanir Pharmaceuticals for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 5 employees and customers of Acorda Therapeutics and 3 employees and customers of Avanir Pharmaceuticals.
Acorda Therapeutics
Acorda Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Acorda Therapeutics. Their current market cap is $45.33M.
Avanir Pharmaceuticals
Avanir Pharmaceuticals's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Avanir Pharmaceuticals.
4/5
Product Quality
1.5/5
1.5/5
Pricing
1.5/5
1.5/5
Customer Service
N/A
| 0% | Promoters |
|---|---|
| 0% | Passive |
| 100% | Detractors |
-100
NPS Score
| 0% | Promoters |
|---|---|
| 0% | Passive |
| 100% | Detractors |
See how Acorda Therapeutics compares to its competitors
See how Avanir Pharmaceuticals compares to its competitors
Working at Acorda Therapeutics vs Working at Avanir Pharmaceuticals
50 / 100
CEO Rating
Winner by 13%
37 / 100
CEO Rating
Acorda Therapeutics
Acorda Therapeutics doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Avanir Pharmaceuticals
Employees at Avanir Pharmaceuticals rate their CEO, Wael Hashad, 37/100. This score is 13% lower than the scores of Acorda Therapeutics' CEO, Ron Cohen.